Join Now

Sumitomo Pharma Oncology Receives Orphan Drug Designation for DSP-5336, an Investigational Menin and Mixed-Lineage Leukemia Binding Protein for Treatment of Acute Myeloid Leukemia

By Press Release | Published August 11, 2022

The U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for DSP-5336.

Posted in BioUtah News | Tagged | Leave a comment

A Special Thanks To Our Elite Members